Project Number 1R03AG070511-01A1 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Directed evolution of tissue inhibitor of metalloproteinase 3 (TIMP-3) to develop novel Alzheimer’s disease (AD) therapeutics Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) r. Multi-target Researcher and Organization Principal Investigator RAEESZADEH SARMAZDEH, MARYAM Principal Investigator First Name MARYAM Principal Investigator Last Name RAEESZADEH SARMAZDEH Awardee Organization UNIVERSITY OF NEVADA RENO Awardee State Nevada Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-19-392: Small Research Grant Program for the Next Generation of Clinical Researchers in AD/ADRD Research: Area of Focus Basic Science (R03 Clinical Trials Not Allowed) FY Overall Cost $299,975 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
